Individual Patient Investigational New Drug (IND) Expanded Access Program of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Participant With Multiple Myeloma
Clinical trial NCT04452994 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04452994
- Sponsor
- Janssen Research & Development, LLC
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.